Imipenem/cilastatin.
D000042:Absorption; D000328:Adult; D000818:Animals; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*; D001419:Bacteria / Q000187:drug effects; D001424:Bacterial Infections / Q000188:drug therapy*; D002648:Child; D015377:Cilastatin; D003521:Cyclopropanes / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology*; D004338:Drug Combinations; D004352:Drug Resistance, Microbial; D006801:Humans; D015378:Imipenem; D007684:Kidney Tubules / Q000378:metabolism; D007700:Kinetics; D013845:Thienamycins / Q000009:adverse effects / Q000378:metabolism / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D003521:Cyclopropanes; D004338:Drug Combinations; D013845:Thienamycins; D015377:Cilastatin; D015378:Imipenem